One step closer to treating spina bifida with stem cells

One step closer to treating spina bifida with stem cells

With the CIRM funding, the UC Davis team will be able to launch their one-of-a-kind treatment in the coming months. It will be delivered while the baby is still in the mother’s womb (in utero). The complex procedure, with its unique use of a stem cell “patch,” could improve outcomes for children who are born with the severe form of spina bifida known as myelomeningocele.

2020 Connexions Magazine Available Online

2020 Connexions Magazine Available Online

award-winning 2020 Connexions magazine, full of updates around fetal research, how our maternal fetal partners are improving outcomes for patient families with conditions such as spina bifida, IUGR and tetralogy of fallot, as well as learning more about PCOS and pregnancy, or the importance around birth photography.

Dr. Chmait Performs Minimally-Invasive Fetoscopic Surgery for Spina Bifida

Dr. Chmait Performs Minimally-Invasive Fetoscopic Surgery for Spina Bifida

“We have a unique approach that is a technique first established in Brazil by Dr. Lapa, and we brought it over to the United States. Dr. Quintero and I have put together a fetoscopic treatment that is FDA approved to repair open spina bifida, that is entirely percutaneous (there is no laparotomy and no hysterectomy),” said Dr. Ramen Chmait, Director, Los Angeles Fetal Surgery.